Serum to urinary sodium concentration ratio is an estimate of plasma renin activity in congestive heart failure

European Journal of Heart Failure

Volumn 4, Issue 5, 2002, Pages 597-603

  Marenzi, GianCarlo ^a   Lauri, Gianfranco ^a   Assanelli, Emilio ^a   Grazi, Marco ^a   Campodonico, Jeness ^a   Famoso, Gabriella ^a   Agostoni, Piergiuseppe ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Heart failure; Plasma renin activity; Sodium concentration; Ultrafiltration

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; RENIN; SODIUM;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; ULTRAFILTRATION;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD UREA NITROGEN; CREATININE; DIURETICS; FEMALE; FUROSEMIDE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; RENIN; SEVERITY OF ILLNESS INDEX; SODIUM; STATISTICS; TREATMENT OUTCOME; ULTRAFILTRATION;

EID: 0036801203     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(02)00097-1     Document Type: Article

References (33)

1. Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med 1985;313:1330-40.
2. Johnson JA, Davis JO. Angiotensin II: Important role in the maintenance of arterial blood pressure. Science 1973;179:906-7.
3. Packer M. Neurohumoral interactions and adaptations in congestive heart failure. Circulation 1988;77:721-30.
4. Schrier RW. Body fluid regulation in health and disease: A unifying hypothesis. Ann Internal Med 1990;113:155-9.
5. Cleland JGF. The renin-angiotensin system in heart failure. Herz 1991;16:68-81.
6. Packer M. How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease. Am J Cardiol 1993;71:3C-11C.
7. Benedict CR, Johnstone DE, Weiner DH, et al. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the registry of Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1994;23:1410-20.
8. V-HeFT VA Cooperative Studies Group, Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of the therapy in V-HeFT II. Circulation 1993;87(Suppl VI):VI-40-8.
9. Rockman HA, Juneau C, Chatterje K, Rouleau JL. Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary disease. Am J Cardiol 1989;64:1344-8.
10. Packer M, Medina N, Yushak M, Lee WH. Usefulness of plasma renin activity in predicting hemodynamic and clinical responses and survival during long-term converting-enzyme inhibition in severe chronic heart failure: Experience in 100 consecutive patients. Br Heart J 1985;54:298-304.
11. Schaer GL, Covit AB, Laragh JH, Cody RJ. Association of hyponatremia with increased renin activity in chronic congestive heart failure: Impact of diuretic therapy. Am J Cardiol 1983;51:1635-8.
12. Levine TB, Franciosa JA, Vrobel T, Cohn JN. Hyponatremia as a marker for high renin heart failure. Br Heart J 1982;47:161-6.
13. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986;73:257-67.
14. Packer M, Lee WH, Kessler PD, Medima N, Yushak M, Gottlieb SS. Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure. J Am Coll Cardiol 1987;10:837-44.
15. Parameshwar J, Keegan J, Sparrow J, Sutton GC, Poole-Wilson PA. Predictors of prognosis in severe chronic heart failure. Am Heart J 1992;123:421-6.
16. Rimondini A, Cipolla CM, Della Bella P, et al. Hemofiltration as a short-term treatment for refractory congestive heart failure. Am J Med 1987;83:43-8.
17. Agostoni PG, Marenzi GC, Pepi M, et al. Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 1993;21:424-31.
18. Agostoni PG, Marenzi GC, Lauri G, et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: Failure of furosemide to provide the same result. Am J Med 1994;96:191-9.
19. Marenzi GC, Grazi S, Giraldi F, et al. Interrelation of humoral factors, hemodynamics and fluid and salt metabolism in congestive heart failure. Effects of extracorporeal ultrafiltration. Am J Med 1993;94:49-56.
20. Guazzi MD, Agostoni PG, Perego GB, et al. The apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. Br Heart J 1994;72:534-9.
21. Naik RB, Mathia CJ, Reid JL, Warren DJ. Effect of hemodialysis on the control of the circulation in patients with chronic renal failure. Am J Nephrol 1985;5:96-102.
22. Francis GS, Goldsmith SR, Levine TB, Olivari MT, Cohn JN. The neurohormonal axis in congestive heart failure. Ann Internal Med 1984;101:370-7.
23. Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy. N Engl J Med 1988;319:1065-72. Part 2: pp. 1127-34.
24. Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC. Control of glomerular filtration rate by reninangiotensin system. Am J Physiol 1977;233:F366-72.
25. Blantz RC. The glomerular and tubular actions of angiotensin II. Am J Kidney Dis 1987;10(Suppl I):2-6.
26. Myers BD, Deen WM, Brenner BM. Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 1975;37:101-10.
27. Cogan MG. Angiotensin II: A powerful controller of sodium transport in the early proximal tubule. Hypertension 1990;15:451-8.
28. Cannon PJ. The kidney in heart failure. N Engl J Med 1977;296:26-32.
29. Riegger GAJ, Liebau G, Holzschah M, Witkowski D, Steilner H, Kochsiek K. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting enzyme inhibition. Am J Cardiol 1984;53:614-8.
30. CONSENSUS Trial Study Group, Swedberg K, Eneroth P, Kjeshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990;82:1730-6.
31. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: Clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987;57:17-22.
32. Dietz R, Waas W, Susselbeck T, Willenbrock R, Osterziel KJ. Improvement of cardiac function by angiotensin converting enzyme inhibition. Sites of action. Circulation 1993;87(Suppl IV):108-16.
33. Marenzi GC, Lauri G, Assanelli E, et al. The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure. Cardiologia 1997;42:1277-83.